Is Ayala Pharmaceuticals, Inc. (ADXS) a Buy, Sell, or Hold?
OTC : ADXS
Ayala Pharmaceuticals, Inc. — Institutional Ownership
$0.60355 USD
$0 (0.0%)
- Volume
- 10.01K
- Average Volume
- 5.05K
- Market Capitalization
- $25.71M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.80
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-04-16 | AYALA PHARMACEUTICALS, INC. | 2.16M | 9.99% |
| 2023-10-23 | aMoon Growth Fund G.P. Limited Partnership | 560.6K | 5.21% |
| 2023-10-23 | aMoon General Partner Ltd. | 560.6K | 5.21% |
| 2023-10-23 | Dr. Yair C. Schindel | 560.6K | 5.21% |
| 2023-10-23 | aMoon Growth Fund Limited Partnership | 560.6K | 5.21% |
| 2023-09-11 | Israel Biotech Fund GP Partners, L.P. | 1.93M | 31.30% |
| 2023-09-11 | Israel Biotech Fund I, L.P. | 1.93M | 31.30% |
| 2023-09-11 | Israel Biotech Fund GP Partners II, L.P. | 434.78K | 8.20% |
| 2023-09-11 | I.B.F Management Ltd. | 2.36M | 35.90% |
| 2023-09-11 | Israel Biotech Fund II, L.P. | 434.78K | 8.20% |
| 2023-02-08 | Jeremy C. Green | 332.35K | 6.80% |
| 2023-02-08 | Redmile Group, LLC | 332.35K | 6.80% |
| 2023-01-30 | aMoon Growth Fund Limited Partnership | 560.6K | 12.20% |
| 2023-01-30 | aMoon Growth Fund G.P. Limited Partnership | 560.6K | 12.20% |
| 2023-01-30 | aMoon General Partner Ltd. | 560.6K | 12.20% |
| 2023-01-30 | Dr. Yair C. Schindel | 560.6K | 12.20% |
| 2022-02-10 | 26-0385758 | - | 0.00% |
| 2022-02-10 | 13-3127734 | - | 0.00% |
| 2021-02-16 | CVI Investments, Inc. | 2M | 2.10% |
| 2021-02-11 | 26-0385758 | 6.07M | 6.50% |
| 2021-02-11 | 13-3127734 | 6.07M | 6.50% |
| 2020-08-03 | Lincoln Park Capital, LLC | 4.59M | 6.94% |
| 2020-08-03 | Jonathan I. Cope | 4.59M | 6.94% |
| 2020-08-03 | Inc. | 4.59M | 6.94% |
| 2020-08-03 | Joshua B. Scheinfeld | 4.59M | 6.94% |
| 2020-08-03 | Lincoln Park Capital Fund, LLC | 4.59M | 6.94% |
| 2020-08-03 | Rockledge Capital Corporation | 4.59M | 6.94% |
| 2020-02-13 | Altium Growth Fund, LP | - | 0.00% |
| 2020-02-13 | Altium Growth GP, LLC | - | 0.00% |
| 2020-02-13 | Altium Capital Management, LP | - | 0.00% |
| 2020-02-12 | 13-3127734 | 3.78M | 7.53% |
| 2020-02-12 | 26-0385758 | 3.78M | 7.53% |
| 2020-01-30 | Heights Capital Management, Inc. | 5M | 8.30% |
| 2020-01-30 | CVI Investments, Inc. | 5M | 8.30% |
| 2020-01-21 | Empery Tax Efficient II, LP | - | 0.00% |
| 2020-01-21 | Ryan M. Lane | - | 0.00% |
| 2020-01-21 | Empery Asset Management, LP | - | 0.00% |
| 2020-01-21 | Martin D. Hoe | - | 0.00% |
| 2019-07-31 | Altium Growth Fund, LP | 2.14M | 9.87% |
| 2019-07-31 | Altium Capital Management, LP | 2.14M | 9.87% |
| 2019-07-31 | Altium Growth GP, LLC | 2.14M | 9.87% |
| 2019-04-12 | Martin D. Hoe | 600K | 7.49% |
| 2019-04-12 | Ryan M. Lane | 600K | 7.49% |
| 2019-04-12 | Empery Asset Management, LP | 600K | 7.49% |
| 2019-04-12 | Empery Tax Efficient II, LP | 457.52K | 5.71% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-04-09 | 13G | 600K | 7.50% |
| 2019-02-14 | Heights Capital Management, Inc. | 3.55M | 4.90% |
| 2019-02-14 | CVI Investments, Inc. | 3.55M | 4.90% |
| 2019-02-13 | Adage Capital Partners GP, L.L.C. | 2.5M | 3.59% |
| 2019-02-13 | Phillip Gross | 2.5M | 3.59% |
| 2019-02-13 | Robert Atchinson | 2.5M | 3.59% |
| 2019-02-13 | Adage Capital Advisors, L.L.C. | 2.5M | 3.59% |
| 2019-02-13 | Adage Capital Partners, L.P. | 2.5M | 3.59% |
| 2018-12-28 | 10) | 3.05M | 4.40% |
| 2018-09-14 | Heights Capital Management, Inc. | 4.17M | 6.00% |
| 2018-09-14 | CVI Investments, Inc. | 4.17M | 6.00% |
| 2018-07-10 | (1) BlackRock, Inc. | 1.4M | 2.70% |
| 2018-02-13 | Adage Capital Partners GP, L.L.C. | 4M | 9.68% |
| 2018-02-13 | Adage Capital Advisors, L.L.C. | 4M | 9.68% |
| 2018-02-13 | Adage Capital Partners, L.P. | 4M | 9.68% |
| 2018-02-13 | Phillip Gross | 4M | 9.68% |
| 2018-02-13 | Robert Atchinson | 4M | 9.68% |
| 2018-01-29 | (1) BlackRock, Inc. | 2.28M | 5.50% |
| 2017-11-09 | Abigail P. Johnson | 614.43K | 1.50% |
| 2017-11-09 | FMR LLC | 614.43K | 1.50% |
| 2017-09-27 | Robert Atchinson | 4.7M | 11.45% |
| 2017-09-27 | Adage Capital Partners, L.P. | 4.7M | 11.45% |
| 2017-09-27 | Adage Capital Partners GP, L.L.C. | 4.7M | 11.45% |
| 2017-09-27 | Adage Capital Advisors, L.L.C. | 4.7M | 11.45% |
| 2017-09-27 | Phillip Gross | 4.7M | 11.45% |
| 2017-02-14 | FMR LLC | 4.1M | 10.30% |
| 2017-02-13 | Broadfin Healthcare Master Fund, Ltd. | 1.52M | 3.81% |
| 2017-02-13 | Kevin Kotler | 1.52M | 3.81% |
| 2017-02-13 | Broadfin Capital, LLC | 1.52M | 3.81% |
| 2017-02-10 | STATE STREET CORPORATION | 621.5K | 1.56% |
| 2017-02-10 | Jérôme G. Pfund | 690.07K | 1.70% |
| 2017-02-10 | Michael L. Sjöström | 690.07K | 1.70% |
| 2017-02-10 | Sectoral Asset Management Inc. | 690.07K | 1.70% |
| 2017-02-07 | 10) | 3.05M | 7.60% |
| 2017-01-30 | (1) BlackRock, Inc. | 2.27M | 5.70% |
| 2016-08-02 | 10) | 3.05M | 8.90% |
| 2016-02-16 | Adage Capital Partners GP, L.L.C. | 5.94M | 17.80% |
| 2016-02-16 | Adage Capital Partners, L.P. | 5.94M | 17.80% |
| 2016-02-16 | Phillip Gross | 5.94M | 17.80% |
| 2016-02-16 | Robert Atchinson | 5.94M | 17.80% |
| 2016-02-16 | Adage Capital Advisors, L.L.C. | 5.94M | 17.80% |
| 2016-02-12 | Michael L. Sjöström | 1.79M | 5.30% |
| 2016-02-12 | STATE STREET CORPORATION | 1.68M | 5.10% |
| 2016-02-12 | Sectoral Asset Management Inc. | 1.79M | 5.30% |
| 2016-02-12 | Jérôme G. Pfund | 1.79M | 5.30% |
| 2016-02-12 | Broadfin Healthcare Master Fund, Ltd. | 1.69M | 5.07% |
| 2016-02-12 | Broadfin Capital, LLC | 1.69M | 5.07% |
| 2016-02-12 | Kevin Kotler | 1.69M | 5.07% |
| 2015-08-12 | Broadfin Capital, LLC | 1.66M | 5.27% |
| 2015-08-12 | Kevin Kotler | 1.66M | 5.27% |
| 2015-08-12 | Broadfin Healthcare Master Fund, Ltd. | 1.66M | 5.27% |
| 2014-12-19 | Phillip Gross | 4.45M | 18.84% |
| 2014-12-19 | Adage Capital Advisors, L.L.C. | 4.45M | 18.84% |
| 2014-12-19 | Adage Capital Partners GP, L.L.C. | 4.45M | 18.84% |
| 2014-12-19 | Adage Capital Partners, L.P. | 4.45M | 18.84% |
| 2014-12-19 | Robert Atchinson | 4.45M | 18.84% |
| 2013-10-30 | Justin Keener | 803.33K | 5.97% |
| 2013-10-24 | Sabby Healthcare Volatility Master Fund, Ltd. | 600K | 4.74% |
| 2012-12-21 | Ironridge Global IV, Ltd. | 32.35M | 6.90% |
| 2012-12-21 | John C. Kirkland | - | 0.00% |
| 2012-12-21 | Keith Coulston | - | 0.00% |
| 2012-12-21 | Richard H. Kreger | - | 0.00% |
| 2012-12-21 | Ironridge Global Partners, LLC | - | 0.00% |
| 2012-12-21 | Brendan T. O’Neil | - | 0.00% |
| 2010-02-16 | Optimus CG II, Ltd. | 11.45M | 9.90% |
| 2010-02-16 | 27-0492860 | 11.45M | 9.90% |
| 2009-05-19 | Centrecourt Asset Management LLC | 3.38M | 3.01% |
| 2009-05-19 | Richard Smithline | 3.38M | 3.01% |
| 2009-05-19 | CAMOFI Master LDC | 2.72M | 2.42% |
| 2009-05-19 | CAMHZN Master LDC | 660K | 0.59% |
| 2009-02-12 | Richard Smithline | 9.93M | 8.90% |
| 2009-02-12 | CAMHZN Master LDC | 1.87M | 1.70% |
| 2009-02-12 | CAMOFI Master LDC | 8.06M | 7.20% |
| 2009-02-12 | Centrecourt Asset Management LLC | 9.93M | 8.90% |
| 2008-02-07 | CAMHZN Master LDC | 5.16M | 1.85% |
| 2008-02-07 | Centrecourt Asset Management LLC | 26.02M | 9.45% |
| 2008-02-07 | Richard Smithline | 26.02M | 9.45% |
| 2008-02-07 | CAMOFI Master LDC | 20.86M | 7.60% |
| 2007-10-25 | Centrecourt Asset Management LLC | 25.84M | 9.99% |
| 2007-10-25 | Richard Smithline | 25.84M | 9.99% |
| 2007-10-25 | CAMOFI Master LDC | 20.68M | 9.99% |
ADXS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.66 | 6.02M | $4M | $4.88M | $8.32M | $7.43M |
| 2022-12-31 | $1.20 | 1.82M | $2.18M | $25.21M | $12000 | -$23.01M |
| 2022-01-31 | $11.12 | 1.61M | $17.94M | $41.61M | $40000 | -$23.63M |
| 2021-01-31 | $56.27 | 762.55K | $42.91M | $25.18M | $6.02M | $23.75M |
| 2020-01-31 | $68.80 | 190.1K | $13.08M | $16.72M | $299K | -$3.35M |
| 2019-01-31 | $459.39 | 3.43M | $1.58B | $44.14M | -$ | $1.53B |
| 2018-01-31 | $3587.88 | 2.7M | $9.69B | $23.9M | -$ | $9.67B |
| 2017-01-31 | $10860.60 | 2.36M | $25.63B | $112.75M | $325.16M | $25.84B |
| 2016-01-31 | $8484.84 | 1.87M | $15.85B | $66.56M | $29549 | $15.79B |
| 2015-01-31 | $11939.38 | 1.14M | $13.62B | $17.61M | $62882 | $13.6B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.66 | 6.02M | $4M | $4.88M | $8.32M | $7.43M |
| 2023-09-30 | $0.94 | 4.78M | $4.5M | $2.12M | $3.48M | $5.85M |
| 2023-06-30 | $1.00 | 4.78M | $4.78M | $7.08M | $1.54M | -$760.66K |
| 2023-03-31 | $1.25 | 4.41M | $5.51M | $16.84M | $1.66M | -$9.67M |
| 2022-12-31 | $1.20 | 1.82M | $2.18M | $2.41M | $1.75M | $1.53M |
| 2022-10-31 | $1.86 | 1.82M | $3.38M | $25.21M | $12000 | -$21.82M |
| 2022-07-31 | $3.61 | 1.82M | $6.56M | $28.15M | $19000 | -$21.57M |
| 2022-04-30 | $6.52 | 1.82M | $11.87M | $32.08M | $27000 | -$20.19M |
| 2022-01-31 | $11.12 | 1.82M | $20.24M | $36.48M | $34000 | -$16.2M |
| 2021-10-31 | $40.53 | 1.82M | $73.78M | $41.61M | $40000 | $32.21M |
| 2021-07-31 | $32.80 | 14.42M | $472.89M | $44.41M | $502K | $428.98M |
| 2021-04-30 | $39.12 | 12.89M | $504.19M | $56.03M | $505K | $448.67M |